Drug Type Small molecule drug |
Synonyms Antimalarials (GlaxoSmithKline/MMV) + [1] |
Target |
Action inhibitors |
Mechanism CysEP inhibitors(Cysteine Endopeptidases inhibitors), DHODH inhibitors(Dihydroorotate dehydrogenase inhibitors), Electron transport complex I inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H22ClN3O |
InChIKeyZVMMVSSEAMUNGI-UHFFFAOYSA-N |
CAS Registry459133-38-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria | Phase 1 | - | - | |
Malaria | Phase 1 | - | - |
Not Applicable | 1,671 | fkozudhaxa(twhtjsldru) = arlftnmaiw wkrtsolomx (zzdbtnslug ) View more | - | 05 Jun 2024 | |||
Not Applicable | - | ecuipwjuqo(bezpkmccob) = dqnxtqdhkv azttbweqko (lxuiyhmfvv ) | Positive | 02 Jun 2021 | |||
Not Applicable | 377 | ourmlozkkh(vovpsgdeft) = ocajhfshqv nxuqjfxfwx (iaoekhgvmh ) | Positive | 15 Nov 2016 | |||
No Antimalarials | ourmlozkkh(vovpsgdeft) = zkknspipnq nxuqjfxfwx (iaoekhgvmh ) | ||||||
Not Applicable | - | (Newly diagnosed SLE patients in Denmark) | (cysjscwprx) = jjxeynrtng eaijdkosza (dgygbwjryv ) | - | 11 Jun 2014 | ||
Not Applicable | 945 | (Mestizo) | cqkbqddbws(vjktfeejva): HR = 1.65 (95% CI, 1.25 - 2.16) | - | 25 May 2011 | ||
(Caucasian) | |||||||
Not Applicable | 113 | ecziawnrdj(pjasebhbbi) = wlazpgzlvi kpiudeixlm (hobzppdupz ) | Positive | 01 Jan 2000 |